World Journal of Clinical Cases - Baishideng Publishing Group

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 12, Issue 18

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

HTML

2411

Figures (1-1)

364

Tables (1-5)

347

Sum=3220

Publishing Process of This Article

Item

Count

Browse

Download

594

Sum=687

Jun 26, 2024 (publication date) through Aug 9, 2025

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Clinical Cases

ISSN

2307-8960

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Cited by in CrossRef

For:	Lin MJ, Zou SB, Zhu BX. Effect of dapagliflozin on uric acid in patients with chronic heart failure and hyperuricemia. World J Clin Cases 2024; 12(18): 3468-3475 [PMID: 38983399 DOI: 10.12998/wjcc.v12.i18.3468]
URL:	https://www.wjgnet.com/2307-8960/full/v12/i18/3468.htm

Number	Citing Articles
1	Xiao-Peng Fu. Dual benefits of sodium-glucose cotransporter 2 inhibitors in metabolic diseases: Diabetes control and gout management. World Journal of Clinical Cases 2025; 13(14): 100262 doi: 10.12998/wjcc.v13.i14.100262 Abstract(316) \| Core Tip(311) \| Full Article(HTML)(952) \| Full Article with Cover (PDF)-524K(67) \| Audio-661K(10) \| Peer-Review Report-220K(59) \| Answering Reviewers-105K(67) \| Full Article (PDF)-338K(93) \| Full Article (XML)-33K(77) \| Times Cited (0) \| Total Visits (2553) \| Open
2	Yi-jiao Men, Yan-ling Dong, Yu Gong, Ya-qing An, Hong-bo Cheng. Combining clinical markers can predict mortality in NYHA IV heart failure. Scientific Reports 2025; 15(1) doi: 10.1038/s41598-025-13274-y